Translational modulation of proteins expressed from bicistronic vectors

Molecular Imaging

Volumn 8, Issue 6, 2009, Pages 305-318

  Banerjee, Debabrata ^a   Mishra, Prasun J ^b   Menon, Lata G ^b   Mishra, Pravin J ^b   Mayer Kuckuk, Philipp ^b   Bertino, Joseph R ^b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BICISTRONIC; BICISTRONIC VECTOR; DIHYDROFOLATE REDUCTASE; FUSION PROTEINS; GENE PRODUCTS; IN-VITRO; PRE-TREATMENT; PROMOTER ELEMENTS; RAPAMYCIN; RAPAMYCIN TREATMENT;

NUCLEIC ACIDS;

PROTEINS;

COMPLEMENTARY DNA; DIHYDROFOLATE REDUCTASE; HYBRID PROTEIN; MESSENGER RNA; METHOTREXATE; RAPAMYCIN;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL STRAIN 3T3; GENE VECTOR; GENETICS; HUMAN; METABOLISM; MOLECULAR CLONING; MOUSE; PROMOTER REGION; PROTEIN SYNTHESIS; REPORTER GENE; TUMOR CELL LINE; WHOLE BODY IMAGING;

ANIMALS; CELL LINE, TUMOR; CLONING, MOLECULAR; DNA, COMPLEMENTARY; GENES, REPORTER; GENETIC VECTORS; HUMANS; METHOTREXATE; MICE; MODELS, GENETIC; NIH 3T3 CELLS; PROMOTER REGIONS, GENETIC; PROTEIN BIOSYNTHESIS; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; SIROLIMUS; TETRAHYDROFOLATE DEHYDROGENASE; WHOLE BODY IMAGING;

EID: 72149086165     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2009.00028     Document Type: Article

References (31)

1. Pyronnet S, Pradayrol L, Sonenberg N. A cell cycle-dependent internal ribosome entry site. Mol Cell 2000; 5: 607-16.
2. Bochkov YA, Palmenberg AC. Translational effi ciency of EMCV IRES in bicistronic vectors is dependent upon IRES sequence and gene location. Biotechniques 2006; 41: 283-4, 286, 288.
3. Holcik M, Korneluk RG. Functional characterization of the X-linked inhibitor of apoptosis (XIAP) internal ribosome entry site element: role of La autoantigen in XIAP translation. Mol Cell Biol 2000; 20: 4648-57.
4. Mitchell SA, Brown EC, Coldwell MJ, et al. Protein factor requirements of the Apaf-1 internal ribosome entry segment: roles of polypyrimidine tract binding protein and upstream of N-ras. Mol Cell Biol 2001; 21: 3364-74.
5. Mitchell SA, Spriggs KA, Coldwell MJ, et al. The Apaf-1 internal ribosome entry segment attains the correct structural conformation for function via interactions with PTB and unr. Mol Cell 2003; 11: 757-71.
6. Hellen CU, Sarnow P. Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev 2001; 15: 1593-612.
7. Mizuguchi H, Xu Z, Ishii-Watabe A, et al. IRES-dependent second gene expression is signifi cantly lower than capdependent fi rst gene expression in a bicistronic vector. Mol Ther 2000; 1: 376-82.
8. Hennecke M, Kwissa M, Metzger K, et al. Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs. Nucleic Acids Res 2001; 29: 3327-34.
9. Banerjee D, Bertino JR. Myeloprotection with drug-resistance genes. Lancet Oncol 2002; 3: 154-8.
10. Bertino JR, Booth BA, Bieber AL, et al. Studies on the inhibition of dihydrofolate reductase by the folate antagonists. J Biol Chem 1964; 239: 479-85.
11. Ercikan-Abali EA, Banerjee D, Waltham MC, et al. Dihydrofolate reductase protein inhibits its own translation by binding to dihydrofolate reductase mRNA sequences within the coding region. Biochemistry 1997; 36: 12317-22.
12. Skacel N, Menon LG, Mishra PJ, et al. Identification of amino acids required for the functional up-regulation of human dihydrofolate reductase protein in response to antifolate treatment. J Biol Chem 2005; 280: 22721-31.
13. Mayer-Kuckuk P, Banerjee D, Malhotra S, et al. Cells exposed to antifolates show increased cellular levels of proteins fused to dihydrofolate reductase: a method to modulate gene expression. Proc Natl Acad Sci U S A 2002; 99: 3400-5.
14. Banerjee D, Schweitzer BI, Volkenandt M, et al. Transfection with a cDNA encoding a Ser31 or Ser34 mutant human dihydrofolate reductase into Chinese hamster ovary and mouse marrow progenitor cells confers methotrexate resistance. Gene 1994; 139: 269-74.
15. Banerjee D, Mayer-Kuckuk P, Capiaux G, et al. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. Biochim Biophys Acta 2002; 1587: 164-73.
16. Longo GS, Izzo J, Gorlick R, et al. Characterization and drug sensitivity of four newly established colon adenocarcinoma cell lines to antifolate inhibitors of thymidylate synthase. Oncol Res 2001; 12: 309-14.
17. Ponomarev V, Doubrovin M, Serganova I, et al. A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. Eur J Nucl Med Mol Imaging 2004; 31: 740-51
18. Capiaux GM, Budak-Alpdogan T, Alpdogan O, et al. Protection of hematopoietic stem cells from pemetrexed toxicity by retroviral gene transfer with a mutant dihydrofolate reductase-mutant thymidylate synthase fusion gene. Cancer Gene Ther 2004; 11: 767-73.
19. Frebourg T, Sadelain M, Ng YS, et al. Equal transcription of wild-type and mutant p53 using bicistronic vectors results in the wild-type phenotype. Cancer Res 1994; 54: 878-81.
20. Franke CA, Rice CM, Strauss JH, Hruby DE. Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants. Mol Cell Biol 1985; 5: 1918-24.
21. Bertino JR, Donohue DR, Gabrio BW, et al. Increased level of dihydrofolic reductase in leucocytes of patients treated with amethopterin. Nature 1962; 193: 140-2.
22. Yang DQ, Halaby MJ, Zhang Y. The Identification of an internal ribosomal entry site in the 5′-untranslated region of p53 mRNA provides a novel mechanism for the regulation of its translation following DNA damage. Oncogene 2006; 25: 4613-9.
23. Moon SH, Kim HW, Kim JS, et al. Cap-independent protein translation is initially responsible for 4-(Nmethylnitrosamino)-1-(3-pyridyl)-butanone (NNK)-induced apoptosis in normal human bronchial epithelial cells. J Vet Sci 2004; 5: 369-78.
24. Lukavsky PJ, Kim I, Otto GA, Puglisi JD. Structure of HCV IRES domain II determined by NMR. Nat Struct Biol 2003; 10: 1033-8.
25. Wang Y, Iyer M, Annala AJ, et al. Noninvasive monitoring of target gene expression by imaging reporter gene expression in living animals using improved bicistronic vectors. J Nucl Med 2005; 46: 667-74.
26. Ngoi SM, Chien AC, Lee CG. Exploiting internal ribosome entry sites in gene therapy vector design. Curr Gene Ther 2004; 4: 15-31.
27. Svitkin YV, Herdy B, Costa-Mattioli M, et al. Eukaryotic translation initiation factor 4E availability controls the switch between cap-dependent and internal ribosomal entry site-mediated translation. Mol Cell Biol 2005; 25: 10556-65.
28. Cencig S, Nanbru C, Le SY, et al. Mapping and characterization of the minimal internal ribosome entry segment in the human c-myc mRNA 5′ untranslated region. Oncogene 2004; 23: 267-77.
29. Svitkin YV, Imataka H, Khaleghpour K, et al. Poly(A)-binding protein interaction with elF4G stimulates picornavirus IRES-dependent translation. RNA 2001; 7: 1743-52.
30. Havenga MJ, Vogels R, Braakman E, et al. Second gene expression in bicistronic constructs using short synthetic intercistrons and viral IRES sequences. Gene 1998; 222: 319-27.
31. Venkatesan A, Dasgupta A. Novel fluorescence-based screen to identify small synthetic internal ribosome entry site elements. Mol Cell Biol 2001; 21: 2826-37.